Advisory Services Network’s Definium Therapeutics DFTX Stock Holding History

Advisory Services Network’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50.3K	Buy	+2,659	New	+$45.1K	﹤0.01%	2623
2025 Q4	–	Sell	-656	Closed	-$7.74K	–	3332
2025 Q3	$7.74K	Buy	+656	New	+$6.12K	﹤0.01%	3375
2024 Q1	–	Sell	-9	Closed	-$33	–	2796
2023 Q4	$33	Buy	+9	New	+$27	﹤0.01%	3827
2023 Q2	–	Sell	-9	Closed	-$29	–	2772
2023 Q1	$29	Sell	9 -16	-64%	-$53	﹤0.01%	3942
2022 Q4	$55	Buy	+25	New	+$69	﹤0.01%	3935

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advisory Services Network's DFTX Position: Q1 2026 in Review

Advisory Services Network opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 2,659 shares worth $50.3K. The stake represents ﹤0.01% of the portfolio and ranks #2623 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in DFTX as recently as Q3 2025.

Advisory Services Network first reported a position in DFTX in Q4 2022 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

Advisory Services Network held 2,659 shares of Definium Therapeutics worth $50.3K as of Q1 2026.
Definium Therapeutics was a new Advisory Services Network position in Q1 2026.
Definium Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #2623 holding.
Advisory Services Network first reported a position in Definium Therapeutics in Q4 2022 and has held it in 5 quarters since.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.